Stocksigma LogoStocksigma Logo

Gufic Biosciences Faces Rejection of NSE Penalty Waiver Application

NSE has rejected Gufic Biosciences' waiver application regarding a penalty of ₹1,72,000 (excluding GST) levied for non-compliance with Regulation 17(1A) of

Gufic Biosciences Faces Rejection of NSE Penalty Waiver Application

Gufic Biosciences Ltd · Others (Uncategorized) · 24 Sept 2026, 8:55 pm

Gufic Biosciences Faces Rejection of NSE Penalty Waiver Application NSE has rejected Gufic Biosciences' waiver application regarding a penalty of ₹1,72,000 (excluding GST) levied for non-compliance with Regulation 17(1A) of SEBI LODR during the quarter ended Sep'24. The violation pertained to appointing an Independent Director aged above 75 years without prior shareholder approval via a special resolution. The company previously paid ₹8,000 each to BSE and NSE for Jun'24, while BSE rejected its waiver on 13th Mar'26. Gufic will pay the pending ₹1,72,000 fine to NSE by 3rd Oct'26.

Original exchange filing (PDF)

More announcements from Gufic Biosciences Ltd

All Gufic Biosciences Ltd announcements